Skip to content

Comparing tissue glue N-Butyl-2-Cyanoacrylate with the suturing material mersilk for the joining of tissue after removing impacted mandibular third molar : a non randomised controlled trial

EFFICACY OF USE OF N-BUTYL-2- CYNOACRYLATE TISSUE ADHESIVE VERSUS MERSILK SUTURE IN CLOSURE OF MUCOPERIOSTEAL FLAP AFTER SURGICAL EXTRACTION OF BILATERAL IMPACTED THIRD MOLAR : A NON-RANDOMISED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056660
Enrollment
14
Registered
2023-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K011- Impacted teeth

Interventions

Intervention1: N-Butyl-2-Cyanoacrylate: N-Butyl-2-Cyanoacrylate is a tissue adhesive used for approximation of tissue. After doing surgical removal of impacted mandibular third molar it will be used s

Sponsors

Swargiya Dadasaheb kalmegh smruti dental college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18-35 years. Patients who have given consent for study and follow up.

Exclusion criteria

Exclusion criteria: Patients with any systemic diseases. Patient who are Pregnant or lactating mother. Patients with signs of acute pericoronitis or active infection. Patients with habits such as smoking, addiction and mouth breathing are excluded Immunocompromised and immunodeficient patients

Design outcomes

Primary

MeasureTime frame
proper approximation of mucoperiosteal flapTimepoint: first , third and seventh day

Secondary

MeasureTime frame
pain and trismusTimepoint: first , third and seventh day

Countries

India

Contacts

Public ContactDrRam Mehendale

Swargiya dadasaheb kalmegh smruti dental college and hospital

aishwarya.kadu@sdk-dentalcollege.edu.in7218622327

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026